The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Colitis-associated cancer (CAC) is a major complication of inflammatory bowel diseases. We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models. Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation. The increased tumor burden is correlated with attenuated levels of IL-1beta and IL-18 at the tumor site. To decipher the nucleotide-binding domain, leucine-rich-repeat-containing (NLR) component that is involved in colitis and CAC, we assessed Nlrp3 and Nlrc4 deficient mice. Nlrp3(-/-) mice showed an increase in acute and recurring colitis and CAC, although the disease outcome was less severe in Nlrp3(-/-) mice than in Pycard(-/-) or Casp1(-/-) animals. No significant differences were observed in disease progression or outcome in Nlrc4(-/-) mice compared with similarly treated wild-type animals. Bone marrow reconstitution experiments show that Nlrp3 gene expression and function in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, is responsible for protection against increased tumorigenesis. These data suggest that the inflammasome functions as an attenuator of colitis and CAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies using different mice deficient for inflammasomes components (including NLRP3, NLRP1, NLRP6, NLRC4 and Caspase-1) found that the inflammasomes protect mice from colitis-associated CRC [120,121,122,123,124].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [121,124,131,132,133].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 2×
“Two families of innate immune receptors, the Tolllike receptors (TLRs) and the nu cleotidebinding domain, leucinerichrepeat containing (NLR) proteins, have emerged as essential mediators of gastrointestinal inflam mation and homeostasis (Akira et al., 2006; Franchi et al., 2006).”
BackgroundGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 4×
“How ever, damage to the colonic epithelial cell layer in the colon initiates the release of various DAMP signals, and DAMPs have the potential to activate the NLRP3 inflam masome.”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 6×
“Jenny P.-Y. Ting: panyun@med.unc.edu Abbreviations used: AOM, azoxymethane; ASC/ PYCARD, Apoptotic Speck protein containing a CARD; CAC, colitisassociated cancer; CRC, colorectal cancer; DAMP, damageassociated molecular pattern; DSS, dextran sulfate sodium; HAI, Histologi cal Activity Index; IBD, inflam matory bowel d…”
BackgroundInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 2×
“AIM2 has been shown to form of commensal normal flora in the intestine (RakoffNahoum et al., 2004; Araki et al., 2005; Fukata et al., 2005).”
BackgroundThe risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959 · cited 1×
“Patients suffering from UC demonstrate a significantly increased risk of colorectal cancer (CRC), which seems to be associated with both the duration of the disease and the degree of mucosal inflammation (Eaden et al., 2001).”
BackgroundAIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627 · cited 16×
“Organ culture supernatants were harvested after incubation for 24 h and IL1, IL18, and TNF levels were determined by ELISA.”
InfluentialIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041 · cited 2×
“…functional Nlrp3, Nlrc4, Pycard, and caspase1 (Casp1) has been previously described (R. Flavell, Yale University, New Haven, CT; V. Dixit, Genentech, Inc., San Francisco, CA; F. Sutterwala, University of Iowa, Iowa City, IA; Adachi et al., 1998; Mariathasan et al., 2004; Sutterwala et al., 2006).”
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839 · cited 5×
“In ad dition to NLRP3, other NLRs, such as NLRC4, can form NLRP3independent inflammasome in response to specific stimuli, such as flagellin (Mariathasan et al., 2004).”
BackgroundInfluential
Cited by
Items 401–500 of 849
Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses
Hiemstra, I. H., Bouma, G., Geerts, D., Kraal, G., & den Haan, J. M. M. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.06.007 · Cited by 44
Subramaniam, R., Mizoguchi, A., & Mizoguchi, E. (2016) · Cancer Research Frontiers · doi:10.17980/2016.1 · Cited by 46
“GWAS studies have identified a link between NLRP1 mutation and CD development (44-46).”
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer
Sonnessa, M., Cioffi, A., Brunetti, O., Silvestris, N., Zito, F. A., Saponaro, C., & Mangia, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01587 · Cited by 44
Liu, F., Wang, X., Cui, Y., Yin, Y., Qiu, D., Li, S., & Li, X. (2021) · Foods · doi:10.3390/foods10112711 · Cited by 41
“However, other studies have shown that Caspase-1−/−/Caspase-11−/− mice become susceptible to colitis, which suggests a protective effect of pyroptosis against colitis [22,23].”
BackgroundTargeting the innate immune system with nanoparticles for cancer immunotherapy
Li, K., Zhang, Z., Mei, Y., Li, M., Yang, Q., Wu, Q., Yang, H., He, L., & Liu, S. (2022) · Journal of Materials Chemistry B · doi:10.1039/d1tb02818a · Cited by 40
NLRP3 inflammasome in digestive diseases: From mechanism to therapy
Qiang, R., Li, Y., Dai, X.-C., & Lv, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978190 · Cited by 40
Nlrp3-dependent IL-1β inhibits CD103+ dendritic cell differentiation in the gut
Mak’Anyengo, R., Duewell, P., Reichl, C., Hörth, C., Lehr, H., Fischer, S. E., Clavel, T., Denk, G., Hohenester, S. D., Kobold, S., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96322 · Cited by 46
“In contradiction to our findings, others have reported an increased susceptibility to DSS-induced colitis in Nlrp3–/– mice, attributed to low IL-18 levels and defective epithelial repair (14, 24).”
BackgroundResultMolecular crosstalk between polyphenols and gut microbiota in cancer prevention
Zeb, F., Naqeeb, H., Osaili, T. M. I., Faris, M. E., Ismail, L. C., Obaid, R. S., Naja, F., Radwan, H. M., Hasan, H. A., Hashim, M. S., et al. (2024) · Nutrition Research · doi:10.1016/j.nutres.2024.01.012 · Cited by 40
Src-family kinase-Cbl axis negatively regulates NLRP3 inflammasome activation
Chung, I., Yuan, S.-N., OuYang, C., Lin, H., Huang, K., Chen, Y.-J., Chung, A., Chu, C., Ojcius, D. M., Chang, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1163-z · Cited by 38
Inflammasome expression is higher in ovarian tumors than in normal ovary
Luborsky, J. L., Barua, A., Edassery, S., Bahr, J. M., & Edassery, S. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227081 · Cited by 39
“Chang [31] used expression profiling to identify mechanisms involved in the malignant transformation of endometriosis to ovarian cancer; 18 genes were identified, including NLRP3, IL1B, and IL-18, which implicated inflammasomes.”
BackgroundEffector functions of NLRs in the intestine: innate sensing, cell death, and disease
Yeretssian, G. (2012) · Immunologic Research · doi:10.1007/s12026-012-8317-3 · Cited by 37
Becker, H. M., Apladas, A., Scharl, M. M., Fried, M., & Rogler, G. (2014) · Digestion · doi:10.1159/000357521 · Cited by 39
He, L., Chen, Y., Wu, Y., Xu, Y. J., Zhang, Z., & Liu, Z. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2477-1 · Cited by 39
Mamantopoulos, M., Ronchi, F., McCoy, K. D., & Wullaert, A. (2018) · Gut Microbes · doi:10.1080/19490976.2017.1421888 · Cited by 40
Inflammasomes in Colitis and Colorectal Cancer: Mechanism of Action and Therapies.
Pandey, A., Shen, C. X., & Man, S. M. (2019) · Europe PMC (PubMed Central) · Cited by 53
Shao, X., Lei, Z., & Zhou, C. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200220112741 · Cited by 37
Monocytes link atherosclerosis and cancer
Pittet, M. J., & Świrski, F. K. (2011) · European Journal of Immunology · doi:10.1002/eji.201141727 · Cited by 40
miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis
Scalavino, V., Piccinno, E., Valentini, A. M., Schena, N., Armentano, R., Giannelli, G., & Serino, G. (2023) · Cells · doi:10.3390/cells12172184 · Cited by 36
RNase-L Deficiency Exacerbates Experimental Colitis and Colitis-associated Cancer
Long, T. M., Chakrabarti, A., Ezelle, H. J., Brennan-Laun, S. E., Raufman, J., Polyakova, I. V., Silverman, R. H., & Hassel, B. A. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f2fd · Cited by 38
“colorectal cancer and recapitulates the key role of inflammation in human malignancies.(9,12,13,16) Thus, innate immune sensors and”
BackgroundInfluentialLXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma
Wang, K., Xu, T., Ruan, H., Xiao, H., Liu, J., Song, Z., Cao, Q., Bao, L., Liu, D., Wang, C., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1345-3 · Cited by 39
Epigenetic regulation of ASC/TMS1 expression: potential role in apoptosis and inflammasome function
Salminen, A., Kauppinen, A., Hiltunen, M. O., & Kaarniranta, K. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1524-9 · Cited by 40
Cario, E. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32833d4b88 · Cited by 41
Wei, W., Ding, M., Zhou, K., Xie, H., Zhang, M., & Zhang, C. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.071 · Cited by 37
Regulation of the gut microbiome by inflammasomes
Chen, G. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.011 · Cited by 38
“Conflicting results were also observed with bone marrow chimera experiments to determine the relative importance of NLRP3 signaling in epithelial versus hematopoietic cells with one study demonstrating the importance of intact NLRP3 signaling in bone marrow-derived cells to reduce colitis susceptibility, but nonhemato…”
InfluentialUnderstanding the Role of Inflammasomes in Rheumatoid Arthritis
Makkar, R., Behl, T., BUNGAU, S. G., Kumar, A., & Arora, S. (2020) · Inflammation · doi:10.1007/s10753-020-01301-1 · Cited by 36
Yan, Z., Da, Q., Li, Z., Lin, Q., Yi, J., Su, Y., Yu, G., Ren, Q., Liu, X., Lin, Z., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.812655 · Cited by 46
Xun, J., Zhou, S., Lv, Z., Wang, B., Luo, H., Zhang, L., Yang, L., Zhang, A., Wu, X., Wang, Z., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109839 · Cited by 36
Immunity and Tolerance Induced by Intestinal Mucosal Dendritic Cells
Aliberti, J. (2016) · Mediators of Inflammation · doi:10.1155/2016/3104727 · Cited by 41
Inflammasomes and the microbiota–partners in the preservation of mucosal homeostasis
Levy, M., Thaiss, C. A., Katz, M. N., Suez, J., & Elinav, E. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0451-7 · Cited by 34
“While a barrier-protective role has been ascribed to IL-18 [9–11], IL-1β exacerbated intestinal inflam-”
BackgroundChen, F., Wu, Y.-L., Cheng, C., Hsiao, Y., Chi, J.-Y., Hung, L., Chang, C., Lai, M., & Wang, J. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-023-00991-7 · Cited by 35
Cytosolic Nucleic Acid Sensors in Inflammatory and Autoimmune Disorders
Khan, S., Godfrey, V., & Zaki, H. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.10.002 · Cited by 36
Flood, B., Manils, J., Nulty, C., Flis, E., Kenealy, S., Barber, G. L., Fay, J., Mills, K. H. G., Kay, E. W., & Creagh, E. M. (2018) · Oncogene · doi:10.1038/s41388-018-0613-5 · Cited by 35
The Proinflammatory Role of Guanylate-Binding Protein 5 in Inflammatory Bowel Diseases
Li, Y., Lin, X., Gao, S., Wang, W., Cheng, S., Wang, W., Huang, Y., 邹一丰, Zhu, R., Jia, K., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.926915 · Cited by 37
Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression
Papafragkos, I., Grigoriou, M., Boon, L., Kloetgen, A., Hatzioannou, A., & Verginis, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889075 · Cited by 34
“Despite these findings, an anti-tumorigenic role of NLRP3 has also been described as for example in NLRP3-deficient animals that showed increased susceptibility to colitis-associated cancer induced by dextran sulfate sodium (DSS) (51).”
BackgroundApoptotic Cells Induce NF-κB and Inflammasome Negative Signaling
Grau, A., Tabib, A., Grau, I., Reiner, I., & Mevorach, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122440 · Cited by 34
Song, Y., Kim, Y.-R., Kim, S. M., Ain, Q. U., Yang, C., Yang, C., & Kim, Y. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.017 · Cited by 35
Role of NOD- like Receptors in Glioma Angiogenesis: Insights into future therapeutic interventions
Saxena, S., & Jha, S. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.02.001 · Cited by 35
“NLRP3 expression, specifically in hematopoietic cells is responsible for protection against tumorigenesis [36].”
BackgroundBauset, C., Lis-López, L., Coll, S., Gisbert-Ferrándiz, L., Macias-Ceja, D. C., Seco-Cervera, M., Navarro, F., Esplugues, J. V., Calatayud, S., Ortiz‐Masiá, D., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10030532 · Cited by 35
Frühbeck, G., Gómez‐Ambrosi, J., Ramírez, B., Becerril, S., Rodríguez, A., Mentxaka, A., Valentí, V., Moncada, R., Reina, G., Baixauli, J., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05124-3 · Cited by 37
“While some studies have shown that Nlrp3 knockout mice featured exacerbated colitis accompanied with decreased intestinal integrity and increased bacteria translocation from the gut to the systemic circulation [24, 25], other reports have demonstrated opposite results in disease severity [26].”
ResultNoncoding RNAs and chronic inflammation: Micro‐managing the fire within
Alexander, M., & O’Connell, R. M. (2015) · BioEssays · doi:10.1002/bies.201500054 · Cited by 33
“receptors (NLRs) on innate immune cells [37].”
Advances in Modeling the Immune Microenvironment of Colorectal Cancer
Yoon, P., Piccolo, N. D., Shirure, V. S., Peng, Y., Kirane, A., Canter, R. J., Fields, R. C., George, S. C., & Gholami, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614300 · Cited by 35
“Through comparisons of wild-type and knockout GEMM colitis mouse models, researchers have demonstrated the critical role of p53 (97), IL-6 and Stat3 (98), TLR4 (99), Pycard, Casp1, and Nlrp3 (100), and Nod1 (101) on tumor formation and growth; all of these factors are implicated in regulation of the immune response.”
BackgroundInflammasomes and Colorectal Cancer
Shahbaz, S. K., Koushki, K., Ayati, S. H., Bland, A. R., Bezsonov, E. E., & Sahebkar, A. (2021) · Cells · doi:10.3390/cells10092172 · Cited by 34
“The authors reported that the deficient mice had a greater predisposition toward colorectal tumorigenesis and a lower survival rate compared to wild-type mice [84,85,89].”
BackgroundMethodResultInfluentialKim, S. H., Shin, M. W., & Kim, S. W. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12875 · Cited by 34
Yang, J., Yang, H., Shun, C., Wang, T.-H., Chien, C., & Kao, J. Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/248585 · Cited by 33
RetractedThey Must Hold Tight: Junction Proteins, Microbiota And Immunity In Intestinal Mucosa
Castoldi, Â., de Aguiar, C. F., Moraes‐Vieira, P. M., & Câmara, N. O. S. (2015) · Current Protein and Peptide Science · doi:10.2174/1389203716666150630133141 · Cited by 37
NLRP1 and NLRP3 inflammasomes as a new approach to skin carcinogenesis (Review)
Ciążyńska, M. A., Bednarski, I. A., Wódz, K., Narbutt, J., & Lesiak, A. (2020) · Oncology Letters · doi:10.3892/ol.2020.11284 · Cited by 47
“Furthermore, the NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer (38).”
BackgroundThe NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers
Gouravani, M., Khalili, N., Razi, S., Keshavarz‐Fathi, M., Khalili, N., & Rezaei, N. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1713755 · Cited by 35
“colorectal carcinogenesis in AOM/DSS model [72,98].”
BackgroundInfluentialHausmann, A., Russo, G., Grossmann, J., Zünd, M., Schwank, G., Aebersold, R. H., Liu, Y., Sellin, M. E., & Hardt, W. (2020) · Cellular Microbiology · doi:10.1111/cmi.13191 · Cited by 35
“However, earlier studies have also implicated, for example, ASC, NAIPs, NLRP3 and NLRP6 as tumour suppressors (Allam et al., 2015; Allen et al., 2010; Das et al., 2006; Normand et al., 2011).”
BackgroundLi, J., Qu, C., Li, F., Chen, Y., Zheng, J., Xiao, Y., Jin, Q., Jin, G., Huang, X., & Jin, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.621835 · Cited by 33
Targeting the unfolded protein response, XBP1, and the NLRP3 inflammasome in fibrosis and cancer
Overley, B., Artlett, C. M., Stephens, C., Sassi‐Gaha, S., Weis, R. D., & Thacker, J. D. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.27820 · Cited by 35
“Also shown was that an increased tumor burden correlated with decreased levels of two key markers of inflammasome activation, IL-1β and IL-18, at the tumor sites.(15)”
BackgroundThe Inflammasome: Regulation of Nitric Oxide and Antimicrobial Host Defence
Ramachandran, R. A., Lupfer, C. R., & Zaki, H. (2018) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2018.01.004 · Cited by 33
Iyer, K., Erkert, L., & Becker, C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1228283 · Cited by 34
“Induction of IFN-λ and IL-18 or IL-22 is essential for an effective antiviral innate immunity in the gut (Zhang et al., 2014; Nice et al., 2015).”
BackgroundInfluentialPyroptosis and the fight against lung cancer
Wang, J., Su, H., Wang, M., Ward, R. J., An, S., & Xu, T. (2024) · Medicinal Research Reviews · doi:10.1002/med.22071 · Cited by 36
“Like NLRP3, AIM2 inflammasome plays a key role in protection against colon tumor progression, 102 – 104 whereas it shows tumor promoting activity in lung cancer.”
Accogli, T., Hibos, C., Milian, L. M., Geindreau, M., Richard, C., Humblin, É., Mary, R., Chevrier, S., Jacquin, É., Bernard, A., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01281-y · Cited by 33
Mladenova, D. N., & Kohonen‐Corish, M. R. J. (2012) · PubMed · Cited by 38
Semaphorin 3F and Netrin-1: The Novel Function as a Regulator of Tumor Microenvironment
Nakayama, H., Kusumoto, C., Nakahara, M., Fujiwara, A., & Higashiyama, S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01662 · Cited by 33
“It has been reported that NLRP3 mediates IL18 secretion to protect individuals from colitis-associated colorectal cancer (Allen et al., 2010; Zaki et al., 2010).”
BackgroundInflammasomes in cancer: Effect of epigenetic and autophagic modulations
Mishra, S. R., Mahapatra, K. K., Behera, B. P., Bhol, C. S., Praharaj, P. P., Panigrahi, D. P., Patra, S., Singh, A., Patil, S., Dhiman, R., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.09.013 · Cited by 31
Busch, M., Ramachandran, H., Wahle, T., Rossi, A., & Schins, R. P. F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.898039 · Cited by 37
“Other studies reported increased colitis symptoms in Nlrp3 mice when compared to WT mice (16, 17).”
ResultWang, L., Hsu, C., Chen, C.-C., Liang, Y. J., Chen, L., Ojcius, D. M., Tsang, N., Hsueh, C., Wu, C., & Chang, Y. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.020594 · Cited by 31
“Identification of Protein Components Involved in Inflammasome Complexes of NPC Cells by iTRAQ-LC-MS/MS Analysis—Many reports have shown that inflammasomes are involved in tumor development (15, 47, 48).”
Inflammasomes in Myeloid Cells: Warriors Within
Jha, S., Brickey, W. J., & Ting, J. P.-Y. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0049-2016 · Cited by 35
Self-citationRoles of the inflammasome in the gut‑liver axis (Review)
Wang, J., Dong, R., & Zheng, S. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9679 · Cited by 43
“Allen et al (57) demonstrated that the NLRP3 inflammasome served a protective role in DSS-induced colitis, and that NLRP3-/- mice exhibited more severe colitis.”
BackgroundRogers, A. B. (2011) · Gut Microbes · doi:10.4161/gmic.2.1.14761 · Cited by 31
Self-citationSmall molecule immuno-oncology therapeutic agents
Toogood, P. L. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.12.044 · Cited by 31
Yu, S., Yin, J., Miao, J., Li, S., Huang, C., Huang, N., Fan, T., Li, X., Wang, Y., Han, S., et al. (2020) · Oncology Reports · doi:10.3892/or.2020.7493 · Cited by 33
“Allen et al found that the NLRP3 inflammasome could suppress colitis‐associated carcinoma development (24), whereas Huang et al demonstrated that NLRP3 inflammasome promoted the development of head and neck squamous cell carcinoma (25).”
BackgroundPrivitera, G., Rana, N., Scaldaferri, F., Armuzzi, A., & Pizarro, T. T. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.806680 · Cited by 32
Non-Canonical Programmed Cell Death in Colon Cancer
Pan, B., Zheng, B., Xing, C., & Liu, J. (2022) · Cancers · doi:10.3390/cancers14143309 · Cited by 32
“Mice with the deficient NLRP gene and the caspase-1 gene are less likely to acquire colitis-related colon cancer [88].”
BackgroundRole of programmed necrosis and cell death in intestinal inflammation
Dagenais, M., Douglas, T., & Saleh, M. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000117 · Cited by 32
HuR: a promising therapeutic target for angiogenesis.
Dong, R., Yang, G., Luo, N., & Qu, Y. (2014) · PubMed Central · doi:10.3978/j.issn.2227-684x.2014.03.02 · Cited by 30
“HuR plays a central role in the stabilization of COX2 against multiple conditions (21-24).”
BackgroundTAp73 upregulates IL-1β in cancer cells: Potential biomarker in lung and breast cancer?
Вихрева, П. Н., Petrova, V., Gökbulut, T., Pestlikis, I., Mancini, M., Daniele, N. D., Knight, R. A., Melino, G., & Amelio, I. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.085 · Cited by 31
Regulation and Sensing of Inflammasomes and Their Impact on Intestinal Health
Ranson, N., Kunde, D., & Eri, R. D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112379 · Cited by 32
“Additionally, Nlrp6 and Nlrp3 have been shown to negatively regulate colitis-associated tumorigenesis [109,110].”
BackgroundFeng, S.-H. (2024) · American Journal of Cancer Research · doi:10.62347/mkan3550 · Cited by 29
“Similar to the previous study [50], our work showed that depletion of NLRP3 and Cas1 enhances cell viability in both HCT116 and HT29 cells.”
BackgroundResultNLRs as Helpline in the Brain: Mechanisms and Therapeutic Implications
Singh, S., & Jha, S. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0957-4 · Cited by 30
Wang, L., Wang, Y., Wang, Z., Qi, Y., Zong, B., Liu, M., Li, X., Zhang, X., Liu, C., Cao, R., et al. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00159.2018 · Cited by 31
“Although one study reports that NLRP3 knockout mice ameliorate DSSinduced colitis and survival rate (3), some studies demonstrate that mice with defects in the NLRP3 inflammasome are at a high risk of developing DSS-induced colitis (1, 36, 44).”
BackgroundNLRP3 activated macrophages promote endometrial stromal cells migration in endometriosis
Zhou, F., Zhao, F., Huang, Q., Lin, X., Zhang, S., & Dai, Y. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103649 · Cited by 31
AIM2 upregulation promotes metastatic progression and PD‐L1 expression in lung adenocarcinoma
Zheng, J., Lin, C., Lee, H., Chang, W., Li, L., Su, C., Lee, K., Chiu, H., & Lin, Y. (2022) · Cancer Science · doi:10.1111/cas.15584 · Cited by 31
Pyroptosis and Its Role in the Modulation of Cancer Progression and Antitumor Immunity
Qi, S., Wang, Q., Zhang, J., Liu, Q., & Li, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810494 · Cited by 32
Du, Q., Wang, Y., Liu, C., Wang, H., Fan, H., Li, Y., Wang, J., Zhang, X., Lu, J., Ji, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7554 · Cited by 30
Ringel-Scaia, V. M., McDaniel, D. K., & Allen, I. C. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2017019158 · Cited by 32
Self-citationMasuda, J., Umemura, C., Yokozawa, M., Yamauchi, K., Seko, T., Yamashita, M., & Yamashita, Y. (2018) · Nutrients · doi:10.3390/nu10101380 · Cited by 32
“Bleeding and diarrhea scores were determined as previously described [29].”
MethodInsights into inflammasome and its research advances in cancer
Cao, X., & Xu, J. (2019) · Tumori Journal · doi:10.1177/0300891619868007 · Cited by 33
Zhu, Y., Guo, Y., Guo, P., Zhang, J., He, Y., Xia, Y., Wei, Z., & Dai, Y. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.004 · Cited by 34
Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis
Wang, S., He, H., Qu, L., Shen, Q., & Dai, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1446486 · Cited by 38
The role of pyroptosis in cancer: key components and therapeutic potential
Liu, Z., Xu, S., Chen, L., Gong, J., & Wang, M. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01932-z · Cited by 32
Therapeutic Significance of NLRP3 Inflammasome in Cancer: Friend or Foe?
Jalali, A. M., Mitchell, K. J., Pompoco, C., Poludasu, S., Tran, S., & Ramana, K. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413689 · Cited by 32
Activation of Platelet NLRP3 Inflammasome in Crohn’s Disease
Zhang, G., Chen, H., Guo, Y., Zhang, W., Jiang, Q., Zhang, S., Han, L., Chen, S., & Xue, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.705325 · Cited by 34
Pro-tumorigenic and Anti-tumorigenic Roles of Pro-inflammatory Cytokines in Cancer
Tahmasebi, S., Alimohammadi, M., Khorasani, S., & Rezaei, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_25-1 · Cited by 42
Epithelial Cell Extrusion Leads to Breaches in the Intestinal Epithelium
Liu, J. J., Davis, E. M., Wine, E., Lou, Y., Rudzinski, J. K., Alipour, M., Boulanger, P., Thiesen, A., Sergi, C. M., Fedorak, R. N., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182807600 · Cited by 29
“IL-1b and IL-18 production resulting from caspase-1 activation has been shown to contribute to intestinal inflammation in some reports,(48,49) whereas other studies suggest that caspase-1 conferred protection against colitis and colitis-associated cancer.(21,22,35,50) The discrepancies in experimental results may due…”
ResultYibcharoenporn, C., Muanprasat, C., Moonwiriyakit, A., Satitsri, S., & Pathomthongtaweechai, N. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s507489 · Cited by 30
Li, B., Shao, S., Yuan, L., Jia, R., Sun, J. P., Ji, Q., Sui, H. X., Zhou, L., Zhang, Y., Liu, H., et al. (2020) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2020.12.004 · Cited by 31
Matsushita, H., Miyake, Y., Takaki, A., Yasunaka, T., KOIKE, K. A., Ikeda, F., Shiraha, H., Nouso, K., & Yamamoto, K. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12711 · Cited by 29
Lee, H.-J., Park, J., Han, Y. M., Gil, H. K., Kim, J.-H., Chang, J. Y., Jeong, M., Go, E., & Hahm, K. B. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1103179 · Cited by 32
“[64] reported that Nlrp3 mice are more susceptible to CAC in the AOM–DSS model than wild-type mice, suggesting that the inability of the colic compartment to clear damaged colonocytes through pyroptosis may favor local carcinogenesis via the selection of mutated tumorigenic cells.”
BackgroundRothschild, D. E., Zhang, Y., Diao, N., Lee, C. K., Chen, K., Caswell, C. C., Slade, D. J., Helm, R. F., LeRoith, T., Li, L., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.039 · Cited by 29
“Here we utilized the AOM + DSS model (Williams et al., 2015a; Allen et al., 2012, 2010).”
MethodInfluentialSelf-citationZeng, Q., Fu, J. L., Korrer, M. J., Gorbounov, M., Murray, P. J., Pardoll, D., Masica, D. L., & Kim, Y. J. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0543 · Cited by 28
“The NLRP3 inflammasome complex, in some colorectal carcinoma models, can confer an anticarcinogenic effect (30-34).”
BackgroundGao, M., Zhang, P., Huang, L., Shao, H., Duan, S., Li, C., Zhang, Q., Wang, W. T., Wu, Y., Wang, J., et al. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.109687 · Cited by 27
Hong, S., Hwang, I., Lee, Y.-S., Park, S., Lee, W., Fernandes‐Alnemri, T., Alnemri, E. S., Kim, Y., & Yu, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.12.020 · Cited by 31
“This tumor-suppressive role of the inflammasome is supported by the finding that Nlrp3 / , ASC / , and caspase-1 / mice are more susceptible to colitis-associated colorectal cancer than wild-type mice [35–37].”
Immunotherapeutic Applications of IL-18
Tsutsui, H., & Nakanishi, K. (2012) · Immunotherapy · doi:10.2217/imt.12.137 · Cited by 25
The role of innate immune signals in antitumor immunity
Jinushi, M. (2012) · OncoImmunology · doi:10.4161/onci.1.2.18495 · Cited by 29
“Recent reports demonstrated that the inflammasome protein NLRP3 serves as a negative regulator of tumorigenesis during carcinogen-induced colon cancer.(43) In this study, NLRP3 protects colonic tissues upon chemical insults in caspase-1 and IL-1β-dependent fashion.”
BackgroundNLRC4, inflammation and colorectal cancer (Review)
Tong, G., Shen, Y., Li, H., Qian, H., & Tan, Z. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5687 · Cited by 28
“However, contrasting find‑ ings from another study did not attribute a significant role to NLRC4 (79).”
ResultProtective and detrimental roles of inflammasomes in disease
Saavedra, P. H. V., Demon, D., Gorp, H. V., & Lamkanfi, M. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0485-5 · Cited by 31
Role of NLRP7 in Normal and Malignant Trophoblast Cells
Nahed, R. A., Mikhael, M. E., Reynaud, D., Collet, C., Lemaître, N., Michy, T., Hoffmann, P., Sergent, F., Marquette, C., Murthi, P., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10020252 · Cited by 25
“In the DSS/AOM cancer model, NLRP3 has been reported to play a protective role [56].”
Background
Metadata
- Authors
- Allen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Lineberger Comprehensive Cancer Center 1 , 2 , 3 , 4 , 5 , 6 , 7
- Corresponding author
- Ting, Jenny P.-Y.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-04-12
- Volume
- 207
- Issue
- 5
- Pages
- 1045-1056
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2867287
- OpenAlex
- W2058590329
- Cited by
- 826
- References
- 44
- Citations by year
- 2026: 28 · 2025: 34 · 2024: 54 · 2023: 54 · 2022: 66 · 2021: 53 · 2020: 43 · 2019: 55 · 2018: 54 · 2017: 61 · 2016: 45 · 2015: 56 · 2014: 51 · 2013: 62 · 2012: 49
- FWCI
- 22.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- VTechWorks (Virginia Tech) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (2t32ar007416-25)
- National Cancer Institute (T32CA009156)
- National Institute of Allergy and Infectious Diseases (F32AI082895, U19AI077437, U19-AI077437-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073338, P30‐DK34987, P30DK034987)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32-AR007416)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD046369)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP3 inflammasome, colitis-associated colorectal cancer, inflammatory bowel disease, carcinogenesis, caspase-1, IL-1β, IL-18, NLRP3 knockout mice, NLRC4, hematopoietic cells, bone marrow reconstitution, DSS-induced colitis, azoxymethane, intestinal polyps
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Colitis, Colon, Cytoskeletal Proteins, Euthanasia, Humans, Neoplasms, Inflammatory Bowel Diseases, Gene Expression Regulation, Neoplastic, Mice, Knockout, Interleukin-18, Tumor Burden, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.